Home Business & Economics

Business & Economics

Featured Image: Women and the power to fight breast cancer Courtesy: © 2017. Fotolia. Used with permission.

Daiichi Sankyo and Gustave Roussy Sign Multi-year and Multi-study Adaptive Phase II Trial Collaboration

Daiichi Sankyo and Gustave Roussy have signed a multi-year, multi-study research collaboration for the ongoing development of DS-1062 and patritumab...
Board of Directors discussing different issues.

Susan Altschuller, Ph.D. Appointed as ImmunoGen’s Senior Vice President and Chief Financial Officer

ImmunoGen announced that Susan Altschuller, Ph.D. has been appointed as the company's Senior Vice President and Chief Financial Officer.“Susan...
Conditionally Active Biologics (CAB)

BioAtla Raises $72.5 Million In Series D Financing to Advance CAB-AXL and CAB-ROR2 Clinical...

San Diego (California-) based BioAtla, a global clinical-stage biotechnology company developing Conditionally Active Biologic antibody therapeutics, confirmed that it...

Immunomedics and Roche Expand Study Collaboration in First-line Metastatic Triple-negative Breast Cancer

Immunomedics and Roche have agreed to expand their clinical trial collaboration to evaluate sacituzumab govitecan-hziy (Trodelvy™), a Trop-2-directed antibody...

Revitope and Junshi Biosciences Sign Research Collaboration to Develop Next Generation Immunotherapies

Cambridge (MA) based Revitope Oncology, a biotechnology company advancing a new class of precision cancer immunotherapies, and Junshi Biosciences,...
Featured Image Courtesy: Byondis Biopharmaceuticals (previously Synthon Biopharmaceuticals, Nijmegen, The Netherlands.

Trastuzumab Duocarmazine Selected to be part of a New Investigational Treatment Arm for the...

The Quantum Leap Healthcare Collaborative™, a 501c(3) charitable organization established as a collaboration between medical researchers at University of...

U.S. Patent for Bolt Biotherapeutics’ Boltbody™ ISAC Platform Technology is a Major Milestone in...

San Francisco Bay Area-based Bolt Biotherapeutics confirmed that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent...
New York Stock Exchange (released under Public Domain license. Photo courtesy 2020 Jean Beaufort.

ADC Therapeutics Completes U.S. $ 267 Million Initial Public Offering

Earlier today, New Ventures Funds, a venture fund targeting investments in companies across healthcare and life sciences, confirmed that...
Suzhou, china, 苏州,中国

First ‘Intelligent Ligase-dependent Conjugation’ Enabling ADC Receives FDA IND Clearance

This week, GeneQuantum Healthcare, a Suzhou, China-based developer of bioconjugate drugs, confirmed that the company has received an Investigational...

Adagene and Tanabe Sign Strategic ADC Development Agreement

Adagene, a Suzhou (China) and San Francisco, California, based clinical-stage biotech company developing novel antibody discovery and engineering technologies...